I.L. Feitshans
Georgetown University Law Center,
United States
Keywords: nanotoxicity regulation nanoregulation law global health global commercialization risk management
Summary:
Nanotechnology is globally in food, clothing, aviation, transport, housing construction, weaponry, medical devices, new medicines and outer space exploration. even though risks associated with the new technology emerges slowly. Because no commercial product is made entirely in the same place from start to finish without any components from other nations, nor is it marketed only in the place where it was made, innovators, must catalogue a multitude of laws and drill down into key subjects across jurisdictions in order to comply with law .Providing all workers and consumers accurate detailed information about Nanomaterial Exposure is a major global health Challenge . Scientists and governments agree that the application of nanotechnology to commerce poses potential risks to human health and the environment , but disagree about methods of risk management, how to design compliance and which risks require highest priority . Unquantified risk is the sole point of scientific consensus . In 2011, WHO started bridging health rights regarding nanoscience from the lab to law . Its Committee of Experts prepared Guidelines, finalized in 2017, offering unprecedented, visionary opportunities to operationalize precautionary principles advancing global health, before any established link between workplace exposure to nanomaterials and subsequent harm. The Guidelines Committee focussed on methods. Punting issues about training that delivers information to workers, it incorporated by reference the treaty, Global Harmonization for Chemical Safety (GHS) a multiphase stepwise disclosure model for employer-based training and information dissemination about health hazards for any work. This article proposes an international nano-risk governance framework with a bioethics commission, empowered to examine questions about nanotechnology and its commercial applications and to disseminate information to the general public. The “Nanotechnology Risk Management and Public Health Protection Act” fills a void in the nanoregulatory landscape, where information is plentiful but trustworthy sources are rare.